Company Profile
Droia Ventures is a Europe-based venture capital firm that invests globally in young drug‑development companies focused exclusively on therapeutics for oncology and genetic diseases, backing programs and platforms that aim for meaningful clinical breakthroughs and patient benefit.
The firm combines capital with in‑house drug development expertise and an operational, hands‑on model: Droia actively scouts science and teams, creates companies, provides Droia Labs as a scientific arm for idea validation, and its investment and development professionals often take interim roles to accelerate portfolio companies from creation through clinical proof of concept.
Droia’s portfolio and activity include multiple platform and program investments and the firm runs dedicated funds, pursuing follow-on rounds and exits for therapeutic companies. It has a focused interest in venture capital, particularly in early-stage drug development companies within the therapeutics sector.
News & Signals (0)
No linked news activity found for this company.